+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

QT-prolonging effects of sparfloxacin, a fluoroquinolone antibiotic, assessed in the in vivo canine model with monophasic action potential monitoring



QT-prolonging effects of sparfloxacin, a fluoroquinolone antibiotic, assessed in the in vivo canine model with monophasic action potential monitoring



Journal of Cardiovascular Pharmacology 36(4): 510-515



Sparfloxacin, a fluoroquinolone antibacterial agent, prolongs cardiac repolarization, which may predispose to torsades de pointes. This study was designed to assess simultaneously the hemodynamic and electrophysiologic effects of sparfloxacin using the halothane-anesthetized, closed-chest in vivo canine model (n = 6). Sparfloxacin was intravenously administered in the following two doses with a pause of 20 min, a clinically relevant dose of 3.0 mg/kg/10 min and a 10 times higher dose of 30 mg/kg/10 min. After the low dose of sparfloxacin, cardiac output increased, heart rate decreased, and ventricular repolarization and refractory periods were prolonged. After the high dose, cardiac output increased, whereas heart rate and mean blood pressure decreased, and ventricular repolarization and effective refractory periods were prolonged. The increment was greater in repolarization than in refractoriness, indicating an increase of electrical vulnerability. Because sparfloxacin prolonged repolarization in a reverse use-dependent manner, its negative chronotropic effect may have potentiated the QT prolongation. Left ventricle preload, left ventricular contraction, and AV nodal as well as intraventricular conduction were minimally affected. These results suggest that caution should be used when administering sparfloxacin to patients having risk factors for QT prolongation.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 011230255

Download citation: RISBibTeXText

PMID: 11026654


Related references

Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential. Japanese Circulation Journal 64(6): 445-451, 2000

Comparison of the electropharmacological effects of verapamil and propranolol in the halothane-anesthetized in vivo canine model under monophasic action potential monitoring. Japanese Circulation Journal 64(10): 777-782, 2000

Effects of nonsedating antihistamine, astemizole, on the in situ canine heart assessed by cardiohemodynamic and monophasic action potential monitoring. Toxicology and Applied Pharmacology 143(1): 89-95, 1997

Effects of lubeluzole on repolarization phase in canine heart assessed by endocardial monophasic action potential recording. Japanese Journal of Pharmacology 67(SUPPL 1): 127P, 1995

Effects of the antihypoxic and neuroprotective drug, lubeluzole, on repolarization phase of canine heart assessed by monophasic action potential recording. Toxicology and Applied Pharmacology 139(1): 109-114, 1996

Torsadogenic action of QT-prolonging drugs, astemizole and haloperidol, assessed by the canine chronic atrioventricular block model. Journal of Pharmacological Sciences 94(Supplement 1): 151P, 2004

Diuretics potentiate monophasic action potential prolonging effects of class III antiarrhythmic drugs in isolated guinea pig hearts. Circulation 90(4 PART 2): I249, 1994

The monophasic action potential: a simple in vivo model to evaluate the effects of antiarrhythmic drugs at atrial level. Romanian Journal of Internal Medicine 36(1-2): 37-46, 2000

The effect of disopyramide on in vivo measurement of monophasic action potential in canine heart muscle. Journal of International Medical Research 4(1 Suppl): 26-30, 1976

Changes of monophasic action potential duration and effective refractory period of three layers myocardium of canine during acute ischemia in vivo. Journal of Huazhong University of Science and Technology. Medical Sciences 25(5): 497-500, 2006

Effects of antiarrhythmic drugs on the monophasic action potential of the canine isolated, blood-perfused ventricular septum preparation. Heart and Vessels 13(4): 181-188, 1999

Effects of antiarrhythmic drugs on the monophasic action potential of the canine isolated, blood-perfused ventricular septum preparation. Heart & Vessels 13(4): 181-188, 1998

Effects of body temperature on the monophasic action potential in vivo of heart in Phrynocephalus przewalskii. Journal of Lanzhou University Natural Sciences. Dec 28; 386: 94-98 Sum 144, 2002

In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrobial Agents and ChemoTherapy 36(12): 2698-2703, 1992

Safety profile of sparfloxacin, a new fluoroquinolone antibiotic. Clinical Therapeutics 21(1): 148-159, 1999